NVIDIA expands healthcare AI push with protein design and radiotherapy

NVIDIA said on Oct. 21, 2026, that it is expanding collaborations in healthcare and life sciences around protein design, autonomous laboratory workflows and adaptive radiotherapy, a move that underscores how the company is using its AI and accelerated-computing stack beyond core chip sales. The announcements, tied to GTC Berlin, included a new open protein-design model with the University of Washington's Institute for Protein Design and further work with Siemens Healthineers on cancer treatment planning, according to NVIDIA's newsroom release. NVIDIA and the UW Medicine Institute for Protein Design introduced RFD4-Proteina, described as a new NVIDIA BioNeMo open model that combines programmable protein design with search capabilities.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to Blockchain.News.